Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI

• Main Authors: Zhao X (Author), Song L (Author), Wang Y (Author), Li J (Author), Zhou J (Author), Chen R (Author), Liu C (Author), Zhou P (Author), Sheng Z (Author), Chen Y (Author), Zhao H (Author), Yan H (Author)
• Format: Book
• Published: Dove Medical Press, 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Xiaoxiao Zhao,1,* Li Song,1,* Ying Wang,1,* Jiannan Li,1 Jinying Zhou,1 Runzhen Chen,1 Chen Liu,1 Peng Zhou,1 Zhaoxue Sheng,1 Yi Chen,1 Hanjun Zhao,1 Hongbing Yan2 1Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical Col...